Coronavirus: Maharashtra to procure 10,000 vials of Remdesivir

ST Staff
Sunday, 7 June 2020

Maharashtra will procure 10,000 vials of the investigational drug Remdesivir to battle coronavirus

There is a continuous rise in the spread of novel coronavirus in Maharashtra with cities such as Mumbai, Pune, Thane, Aurangabad are badly hit. After the government gave some relaxations on the fifth phase of the lockdown, the number of cases are surging with a rapid speed.

The state government on Saturday stated that it will be acquiring 10,000 vials of the investigational drug Remdesivir to battle the outbreak in Maharashtra.

According to ANI, Rajesh Tope, Health Minister of the state on Saturday said, “Maharashtra Government will procure 10,000 vials of Remdesivir drug. World Health Organisation suggests the drug may have some positive effects in the treatment of COVID-19.” “Remdesivir is an expensive drug and will be available for all needy in the state,” he added.

Rajesh Tope on his Twitter handle said, "GoM to procure 10k vials of Remdesivir. Based on evidence from Laboratory, animal and clinical studies, It has generated promising results in MERS-CoV and SARS which are also caused by Corona Virus".

"WHO (World Health Organisation) suggests it may have some positive effects in Covid-19 treatment. This expensive medicine is being made available for poor & needy patients," he wrote.

Meanwhile, the government has also established a committee of four members to fix rates for COVID-19 testing in private laboratories around the state. The committee will choose the fees of the test in a private laboratory within 7 days.

Sudhakar Shinde, CEO, State Health Assurance Society will lead the committee. which will also possess Ajay Chandanwale, Joint Director of Directorate of Medical Education and Research. Professor Amita Joshi of Grant Government Medical College and Hospital is also in the committee.

44 government and 36 private laboratories are given permission to perform COVID-19 tests, according to the Indian Council of Medical Research (ICMR).


Remdesivir is a nucleotide analogue with broad-spectrum antiviral activity. The drug has established in animal models against the viral pathogens MERS and SARS, which are similar to COVID-19. Primary reports display patients with advanced coronavirus and lung involvement recovered faster after the use of Remdesivir.

Related News

​ ​